chr10-17157781-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_004412.7(TRDMT1):c.547C>T(p.Leu183=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00178 in 1,559,358 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0093 ( 19 hom., cov: 33)
Exomes 𝑓: 0.00097 ( 19 hom. )
Consequence
TRDMT1
NM_004412.7 synonymous
NM_004412.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.531
Genes affected
TRDMT1 (HGNC:2977): (tRNA aspartic acid methyltransferase 1) This gene encodes a protein responsible for the methylation of aspartic acid transfer RNA, specifically at the cytosine-38 residue in the anticodon loop. This enzyme also possesses residual DNA-(cytosine-C5) methyltransferase activity. While similar in sequence and structure to DNA cytosine methyltransferases, this gene is distinct and highly conserved in its function among taxa. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 10-17157781-G-A is Benign according to our data. Variant chr10-17157781-G-A is described in ClinVar as [Benign]. Clinvar id is 780850.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.531 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00927 (1411/152226) while in subpopulation AFR AF= 0.0326 (1352/41528). AF 95% confidence interval is 0.0311. There are 19 homozygotes in gnomad4. There are 660 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 19 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRDMT1 | NM_004412.7 | c.547C>T | p.Leu183= | synonymous_variant | 8/11 | ENST00000377799.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRDMT1 | ENST00000377799.8 | c.547C>T | p.Leu183= | synonymous_variant | 8/11 | 1 | NM_004412.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00926 AC: 1409AN: 152108Hom.: 19 Cov.: 33
GnomAD3 genomes
AF:
AC:
1409
AN:
152108
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00274 AC: 591AN: 215742Hom.: 11 AF XY: 0.00184 AC XY: 215AN XY: 116996
GnomAD3 exomes
AF:
AC:
591
AN:
215742
Hom.:
AF XY:
AC XY:
215
AN XY:
116996
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000971 AC: 1367AN: 1407132Hom.: 19 Cov.: 30 AF XY: 0.000846 AC XY: 589AN XY: 696026
GnomAD4 exome
AF:
AC:
1367
AN:
1407132
Hom.:
Cov.:
30
AF XY:
AC XY:
589
AN XY:
696026
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00927 AC: 1411AN: 152226Hom.: 19 Cov.: 33 AF XY: 0.00887 AC XY: 660AN XY: 74426
GnomAD4 genome
AF:
AC:
1411
AN:
152226
Hom.:
Cov.:
33
AF XY:
AC XY:
660
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 14, 2017 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at